This episode provides an introduction to cell and gene therapies and touches upon the historical, scientific, clinical, policy and regulatory considerations surrounding their development and use, with forward-looking perspectives from our guests on the future of this new chapter of medicine.
Guests:
· Professor Luigi Naldini, Director, San Raffaele Telethon Institute for Gene Therapy
· Avril Daly, Vice-president, Rare Diseases Europe (EURORDIS); CEO, Retina International
----
Abbreviations:
· CAR T cells: chimeric antigen receptor T cells
· HTA: Health technology assessment
